Chelsea Clinton

CLOV

Chelsea Clinton serves as Director at Clover Health Investments, Corp. (CLOV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$252.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$252.5K

Companies Traded

CLOV

Active Period

Mar 2022

1 total trades

Most Recent

Buy CLOV

Mar 4, 2022 · $252.5K

Chelsea Clinton's Insider Trading at Clover Health Investments, Corp. (CLOV)

Buys

1 · $252.5K

Sells

0 · $0.00

Total Shares Bought

100,000

Total Shares Sold

CLOV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 4, 2022	Buy	100,000	$2.53	$252.5K	100,000

Related Insiders

Jamie L. Reynoso

officer: CEO, Medicare Advantage

CLOVSell · Mar 18, 2026

Karen Soares

General Counsel & Secretary

CLOVSell · Feb 14, 2026

Andrew Toy

Chief Executive Officer

CLOVSell · Feb 8, 2026

Peter J. Kuipers

Chief Financial Officer

CLOVSell · Jan 29, 2026

Conrad Wai

CEO, Counterpart Health

CLOVSell · Jan 15, 2026

Brady Patrick Priest

CEO of Home Care

CLOVSell · Jan 15, 2026

Vivek Garipalli

Director

CLOVSell · Jan 7, 2026

Anna U Loengard

Director

CLOVBuy · Aug 13, 2025

Explore More Insider Trading Data

CLOV Insider Trading Activity

View all insider trades at Clover Health Investments, Corp.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity